Biotech Showcase

Thank you for your interest in presenting at China Showcase 2020.

If selected for a China Showcase presentation slot, you will be required to pay both the registration and presentation fee. Note, these fees include the presenter only. Additional company attendees are welcome to attend by registering and paying the applicable registration fee ($895.00)

The China Showcase is a one-day event taking place on Sunday, January 12, 2020. Those wishing to participate in both Biotech Showcase and China Showcase will need to register for the Biotech Showcase and pay the applicable registration fee. Biotech Showcase information can be found here. The organizers will contact you directly if your company is selected for a presentation slot.

Registration Fee:
Presentation fees:
Public Slot (30 - min.) $895
Private Slot(15 - min.) $595

Please note: once your company is selected and accepts the offer of a presentation slot, you will be required to pay the registration and presentation fees within 10 business days to secure a time slot. Failure to pay fees in a timely manner may result in a delay in scheduling your presentation time and day.

To qualify for China Showcase, your company must be a public or privately held life science company actively developing therapeutics. The China Showcase features companies in the following broad groups:

  • Small/large molecular R&D therapeutic
  • Platform
  • Tool
  • Delivery
  • Molecular diagnostic and personalized medicine
  • Digital Medicine
  • Medtech
  • Research focused service providers

To request a China Showcase presentation slot please complete the following Investor Summary Profile (ISP).

The information in your ISP will be used to evaluate if your company qualifies for reduced registration. If your company is offered a presentation slot and you accept that offer, some or all or portions of your ISP may be used as follows:

  • Posted on the Biotech Showcase/China Showcase 2020 website and used in promotional materials.
  • Distributed to investors and other biopharmaceutical executives prior to the conference.
  • Published in the Biotech Showcase/China Showcase 2020 Handbook of Presenting Companies.

Please be as accurate as possible. Demy-Colton and EBD Group reserve the right to edit the information you provide to meet our formatting needs as well as to ensure accuracy.

Please complete the following fields Indicates a required field

Please do not copy and paste text in to this form. To ensure text does not exceed word limits, type the text in to the cell and observe word limit counter below.

Company Name
(Please provide full and complete legal company name)
Presenter's Contact Name
Presenter's Job Title
Presenter's Contact Email
Presenter's Contact Phone
Corporate Communications / IR Contact
Corporate Communications / IR Contacts Email
Corporate Communications / IR Contact Phone
Assistant's Name
Assistant's Email
Assistant's Phone
Company Ownership Public Private
IPO Year
Primary Stock Exchange
Ticker Symbol
If private, do you intend to go public before the conference? Yes No
Street Address:
Year Established
Number of Employees
Company Summary
Investor Proposition This section should include the top line reason your firm will attract investments.
Company Classification Please select primary and secondary, if applicable

Therapeutic Focus/Product
DRAG/DROP selected focus areas Your Therapeutic Focus/Products in order of priority
  • Antibodies
  • Artificial Intelligence (AI)
  • Autoimmune
  • Big Data
  • Bioinformatics
  • Biomanufacturing
  • Biosimilars
  • Cardiovascular
  • CNS \ Neurological
  • Contract Drug Development
  • Contract Manufacturing
  • Dermatology
  • Diagnostics
  • Drug Delivery
  • Drug Discovery
  • Endocrine/Metabolic
  • Epigentic
  • Fibrosis
  • Functional Genomics
  • Gastrointestinal
  • Gene/Cell Therapy
  • Generics
  • Genitourinary
  • Genomics
  • Hematology
  • Hepatic
  • Immunology
  • Immuno-oncology
  • Infectious Disease
  • Inflammation
  • Machine Learning
  • Microarrays
  • Microbiome
  • Mitochondrial Therapeutic
  • Musculoskeletal
  • Neurology
  • Neuropathy
  • Oncology
  • Opthalmic
  • Orphan/Rare Disease
  • Other
  • Personalized Medicine
  • Pharmacogenetics
  • Platform Technology
  • Proteomics
  • Pulmonary
  • Regenerative Medicine
  • Renal
  • Reproductive Medicine
  • Research Tools
  • Transplant
  • Vaccines
  • Veterinary
  • Women's Health

Please describe your development program

Use the "Add New Asset" button below to identify your primary development programs.

The Assets field has been added to the ISP to better communicate your company’s value to the investor community. Please add at least one Asset. You can also add more if applicable.

Funding Plans China Showcase 2020 is an investor conference. Please let us know your fundraising plans:
Major Investors
Corporate Partners
Funds Raised to Date If you do not wish for this information to be included in the conference Handbook, next to the information provided include the following “Do Not Include in Handbook".
Additional Comments

By clicking Submit, you agree to the Biotech Showcase Terms and Conditions, published by EBD Group on behalf of EBD Group and Demy Colton. Demy-Colton Privacy Policy.